| 产品详情 |
| Edit |   |
|---|
| Product Name | A77 1726 (E/Z) Mixture |
|---|
| Description | rac A77 1726 is the active metabolite of Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis. LEF-M interferes with dendritic cell function. The second Phase III study evaluating the efficacy of Genzyme's teriflunomide therapy against relapsing forms of multiple sclerosis found the once-daily oral drug to be no less effective than injectable interferon beta 1a (Rebif®). Leflunomide USP Related Compound B. Molecular Formula: C12H9F3N2O2 Solubility: DMSO (Slightly), Methanol (Sparingly) Molecular Weight: 270.20999999999998 |
|---|
| Size | 50mg, 100mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 440642 |
|---|
| Price | |
|---|
| Order / More Info | A77 1726 (E/Z) Mixture from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|